Access to Medicine Versus Test Data Exclusivity Safeguarding Flexibilities Under International Law /
| Príomhchruthaitheoir: | |
|---|---|
| Údar corparáideach: | |
| Achoimre: | XVI, 256 p. 78 illus., 56 illus. in color. text  | 
| Teanga: | Béarla | 
| Foilsithe / Cruthaithe: | 
        Berlin, Heidelberg :
          Springer Berlin Heidelberg : Imprint: Springer,
    
        2016.
     | 
| Eagrán: | 1st ed. 2016. | 
| Sraith: | Munich Studies on Innovation and Competition,
              4             | 
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1007/978-3-662-49655-8 | 
| Formáid: | Leictreonach LEABHAR | 
                Clár na nÁbhar: 
            
                  - Introduction
 - Test Data Exclusivity: Raison d'être
 - Test Data Exclusivity and Art 39(3) TRIPS
 - Test Data Exclusivity in the US and the EU
 - Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements
 - Index of Data Exclusivity and Access (IDEAS) - National Laws
 - Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals
 - Conclusions and Recommendations.